Login to Your Account

Forma/Genentech Unusual Deal Proves Big Science Still Pays

By Trista Morrison

Tuesday, June 28, 2011
Drug discovery firm Forma Therapeutics Inc. has always been unconventional, and its latest deal with Roche AG's Genentech subsidiary is no exception.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription